Literature DB >> 29378038

Cashew Nut Consumption Increases HDL Cholesterol and Reduces Systolic Blood Pressure in Asian Indians with Type 2 Diabetes: A 12-Week Randomized Controlled Trial.

Viswanathan Mohan1, Rajagopal Gayathri2, Lindsay M Jaacks3, Nagarajan Lakshmipriya2, Ranjit Mohan Anjana1, Donna Spiegelman3,4, Raman Ganesh Jeevan2, Kandappa K Balasubramaniam2, Shanmugam Shobana2, Mathialagan Jayanthan2, Viswanathan Gopinath2, Selvakumar Divya2, Vasudevan Kavitha2, Parthasarathy Vijayalakshmi2, Mookambika Ramya Bai R2, Ranjit Unnikrishnan1, Vasudevan Sudha2, Kamala Krishnaswamy2, Jordi Salas-Salvadó5, Walter C Willett4,6.   

Abstract

Background: There is increasing evidence that nut consumption decreases the risk of cardiovascular disease. However, there are few data on the health effects of cashew nuts among adults with type 2 diabetes (T2DM). Objective: The study aimed to investigate the effects of cashew nut supplementation on glycemia, body weight, blood pressure, and lipid profile in Asian Indians with T2DM.
Methods: In a parallel-arm, randomized controlled trial, 300 adults with T2DM [mean ± SD age: 51 ± 9.3 y; body mass index (BMI; in kg/m2): 26.0 ± 3.4; 55% male] were randomly assigned to receive advice to follow a standard diabetic diet (control) or similar advice plus 30 g cashew nuts/d (intervention) for 12 wk. The macronutrient composition of the prescribed diabetic diet was 60-65% energy from carbohydrates, 15-25% from fat, and the rest from protein. Differences between groups in changes in anthropometric and biochemical variables were analyzed using linear models with robust variance estimation under an assumed independence working correlation.
Results: Participants in the intervention group had a greater decrease in systolic blood pressure from baseline to 12 wk than did controls (-4.9 ± 13.7 compared with -1.7 ± 11.6 mm Hg; P = 0.04) and a greater increase in plasma HDL cholesterol compared with controls (+1.7 ± 5.6 compared with +0.1 ± 4.6 mg/dL; P = 0.01). There were no differences between the groups with respect to changes in body weight, BMI, blood lipid, and glycemic variables. Plasma oleic acid concentrations and self-reported dietary intake of nuts, oleic acid, and monounsaturated fatty acids suggested excellent compliance with the nut consumption.
Conclusion: Cashew nut supplementation in Asian Indians with T2DM reduced systolic blood pressure and increased HDL cholesterol concentrations with no deleterious effects on body weight, glycemia, or other lipid variables. This study was registered at the clinical trial registry of India as CTRI/2017/07/009022.
© 2018 American Society for Nutrition. All rights reserved.

Entities:  

Keywords:  body weight; cashew nut; high-density lipoprotein cholesterol; type 2 diabetes

Mesh:

Substances:

Year:  2018        PMID: 29378038     DOI: 10.1093/jn/nxx001

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  21 in total

1.  The effect of nuts on markers of glycemic control: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Alyssa M Tindall; Emily A Johnston; Penny M Kris-Etherton; Kristina S Petersen
Journal:  Am J Clin Nutr       Date:  2019-02-01       Impact factor: 7.045

Review 2.  Nuts and Cardiovascular Disease Prevention.

Authors:  A M Coates; A M Hill; S Y Tan
Journal:  Curr Atheroscler Rep       Date:  2018-08-09       Impact factor: 5.113

3.  A Prospective Study of Nut Consumption and Risk of Primary Hepatocellular Carcinoma in the U.S. Women and Men.

Authors:  Jing Sui; Wanshui Yang; Yanan Ma; Tricia Y Li; Tracey G Simon; Jeffrey A Meyerhardt; Geyu Liang; Edward L Giovannucci; Andrew T Chan; Xuehong Zhang
Journal:  Cancer Prev Res (Phila)       Date:  2019-04-30

4.  Plasma Concentration of Essential and Toxic Trace Elements After Brazil Nut Intake: Results from a Randomized Controlled Trial.

Authors:  Graziela Biude Silva Duarte; Bruna Zavarize Reis; Marcelo Macedo Rogero; Fernando Barbosa; Cintia Cercato; Silvia Maria Franciscato Cozzolino
Journal:  Biol Trace Elem Res       Date:  2022-04-29       Impact factor: 3.738

Review 5.  The Effect of Dietary Interventions on Hypertriglyceridemia: From Public Health to Molecular Nutrition Evidence.

Authors:  Karla Paulina Luna-Castillo; Xochitl Citlalli Olivares-Ochoa; Rocío Guadalupe Hernández-Ruiz; Iris Monserrat Llamas-Covarrubias; Saraí Citlalic Rodríguez-Reyes; Alejandra Betancourt-Núñez; Barbara Vizmanos; Erika Martínez-López; José Francisco Muñoz-Valle; Fabiola Márquez-Sandoval; Andres López-Quintero
Journal:  Nutrients       Date:  2022-03-05       Impact factor: 5.717

Review 6.  Are fatty nuts a weighty concern? A systematic review and meta-analysis and dose-response meta-regression of prospective cohorts and randomized controlled trials.

Authors:  Stephanie K Nishi; Effie Viguiliouk; Sonia Blanco Mejia; Cyril W C Kendall; Richard P Bazinet; Anthony J Hanley; Elena M Comelli; Jordi Salas Salvadó; David J A Jenkins; John L Sievenpiper
Journal:  Obes Rev       Date:  2021-09-08       Impact factor: 10.867

Review 7.  The Effect of MUFA-Rich Food on Lipid Profile: A Meta-Analysis of Randomized and Controlled-Feeding Trials.

Authors:  Xinyi Cao; Jiayue Xia; Yuhao Zhou; Yuanyuan Wang; Hui Xia; Shaokang Wang; Wang Liao; Guiju Sun
Journal:  Foods       Date:  2022-07-05

Review 8.  Naturally Occurring PCSK9 Inhibitors.

Authors:  Maria Pia Adorni; Francesca Zimetti; Maria Giovanna Lupo; Massimiliano Ruscica; Nicola Ferri
Journal:  Nutrients       Date:  2020-05-16       Impact factor: 5.717

9.  Possible inflammatory responses in hypercholesterolemia patients receiving treatment using raw liquid extract of young cashew leaves in herbal homes in Nigeria.

Authors:  Mathew Folaranmi Olaniyan; Donatus F N Ozuruoke; Temitayo Afolabi
Journal:  Int J Health Sci (Qassim)       Date:  2019 Jan-Feb

Review 10.  Functional Foods and Bioactive Compounds: A Review of Its Possible Role on Weight Management and Obesity's Metabolic Consequences.

Authors:  Melina Konstantinidi; Antonios E Koutelidakis
Journal:  Medicines (Basel)       Date:  2019-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.